Previous Close | 57.98 |
Open | 58.32 |
Bid | 58.30 x 800 |
Ask | 58.35 x 800 |
Day's Range | 57.90 - 58.63 |
52 Week Range | 52.77 - 83.25 |
Volume | |
Avg. Volume | 8,921,500 |
Market Cap | 73.428B |
Beta (5Y Monthly) | 0.53 |
PE Ratio (TTM) | 10.31 |
EPS (TTM) | 5.66 |
Earnings Date | Nov 06, 2024 |
Forward Dividend & Yield | 2.66 (4.59%) |
Ex-Dividend Date | Jul 22, 2024 |
1y Target Est | 63.95 |
Based on the average brokerage recommendation (ABR), CVS Health (CVS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
California Gov. Gavin Newsom will soon decide whether the most populous U.S. state will join 25 others in regulating the middlemen known as pharmacy benefit managers, or PBMs, whom many policymakers blame for the soaring cost of prescription drugs.
The latest trading day saw CVS Health (CVS) settling at $57.98, representing a +0.78% change from its previous close.